We are live on ! Find out more
EAM

EULAV Asset Management Portfolio holdings

AUM $3.13B
1-Year Est. Return 23.04%
This Fund
S&P 500
This Quarter Est. Return
+12.68%
1 Year Est. Return
+23.04%
3 Year Est. Return
+90.7%
5 Year Est. Return
+115.08%
10 Year Est. Return
+583.23%
AUM
$2.33B
AUM Growth
+$160M
Cap. Flow
-$38.4M
Cap. Flow %
-1.65%
Top 10 Hldgs %
17.73%
Holding
303
New
23
Increased
54
Reduced
70
Closed
15

Top Buys

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$13.1M
2
EA icon
Electronic Arts
EA
+$5.8M
3
BABA icon
Alibaba
BABA
+$5.66M
4
EXEL icon
Exelixis
EXEL
+$4.48M
5
CDNS icon
Cadence Design Systems
CDNS
+$4.26M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$9.66M
2
TSLA icon
Tesla
TSLA
+$7.37M
3
GD icon
General Dynamics
GD
+$5.05M
4
LKQ icon
LKQ Corp
LKQ
+$4.76M
5
PEP icon
PepsiCo
PEP
+$4.64M

Sector Composition

Rank Sector Weight
1 Technology 23.65%
2 Healthcare 20.51%
3 Industrials 17.93%
4 Consumer Discretionary 13.11%
5 Financials 9.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KLXI
301
DELISTED
KLX Inc.
KLXI
-9,132
Closed -$554K
ILG
302
DELISTED
ILG, Inc Common Stock
ILG
-36,000
Closed -$1.19M
VR
303
DELISTED
Validus Hold Ltd
VR
-34,200
Closed -$2.31M

Similar funds

EULAV Asset Management's Q3 2018 Portfolio in Review

As of Q3 2018, EULAV Asset Management held 303 positions worth $2.33B, up 7.4% from $2.17B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

EULAV Asset Management's Q3 2018 filing shows 23 new, 54 increased, 70 reduced and 15 closed positions. Its largest new stake was NXP Semiconductors: 137,000 shares worth $11.7M. The largest sale was Alexion Pharmaceuticals, an estimated $9.66M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.

  • EULAV Asset Management's largest Q3 2018 buy was NXP Semiconductors: 137,000 shares worth $11.7M.
  • EULAV Asset Management added most to Alibaba in Q3 2018, an estimated $5.66M increase.
  • EULAV Asset Management's biggest Q3 2018 reduction was Alexion Pharmaceuticals, cutting an estimated $9.66M.
  • EULAV Asset Management fully exited Tesla in Q3 2018, selling an estimated $7.37M.
  • EULAV Asset Management's ten largest holdings make up 18% of its $2.33B portfolio in Q3 2018.
  • EULAV Asset Management opened 23 new positions and closed 15 in Q3 2018.
  • EULAV Asset Management's portfolio value rose 7.4% quarter-over-quarter to $2.33B.

Based on EULAV Asset Management's 13F filing for Q3 2018, filed 26 Oct 2018.